Content about LONDON

April 19, 2011

The ever-increasing popularity of vitamin D may have reached its plateau, suggested a report issued by Euromonitor International in late March, in part because of the vitamin’s ubiquity across the marketplace.

LONDON — The ever-increasing popularity of vitamin D may have reached its plateau, suggested a report issued by Euromonitor International in late March, in part because of the vitamin’s ubiquity across the marketplace.

Accordingly, sales of vitamin D supplements may fall, especially sales of single-letter vitamin D, the report concluded.

April 15, 2011

Canada’s London Drugs on Thursday announced it was picking up distribution of Cana International Distributing’s Just In Case — a fashion-centric compact that bridges beauty and sexual heath.

VANCOUVER, British Columbia — Canada’s London Drugs on Thursday announced it was picking up distribution of Cana International Distributing’s Just In Case — a fashion-centric compact that bridges beauty and sexual heath.

The JIC compact looks like a mirrored makeup compact and has a hidden compartment to hold condoms, the retailer stated.

April 14, 2011

GlaxoSmithKline on Thursday identified the remaining noncore over-the-counter brands that it intends to divest as the company focuses its Consumer Healthcare business around a portfolio of fast-growing priority brands and emerging markets.

LONDON — GlaxoSmithKline on Thursday identified the remaining noncore over-the-counter brands that it intends to divest as the company focuses its Consumer Healthcare business around a portfolio of fast-growing priority brands and emerging markets.

GSK said it planned to contact companies interested in acquiring the brands over the next few weeks and expected to complete all divestitures by late 2011.

March 29, 2011

Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

LONDON — Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

The firm released a report Monday showing that the global biosimilars market, whose value stood at $243 million in 2010, will increase to $3.7 billion by 2015.

March 24, 2011

GlaxoSmithKline withdrew all regulatory approval applications for a drug designed to cut men's risk of developing prostate cancer.

LONDON — GlaxoSmithKline withdrew all regulatory approval applications for a drug designed to cut men's risk of developing prostate cancer.

The drug maker announced it no longer would pursue global approval for Avodart (dutasteride) and would work with regulatory agencies to remove the indication from the product’s license.

March 18, 2011

With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

LONDON — With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

February 23, 2011

Jemma Kidd Make Up School is slated to debut on QVC on March 4, offering on-air tips and step-by-step instructions for professional application.

NEW YORK — Jemma Kidd Make Up School is slated to debut on QVC on March 4, offering on-air tips and step-by-step instructions for professional application.

February 10, 2011

Public policies to support medical innovation will help drug companies address diseases that devastate people’s lives, a drug company executive said at a summit Thursday.

LONDON — Public policies to support medical innovation will help drug companies address diseases that devastate people’s lives, a drug company executive said at a summit Thursday.

Speaking at The Economist magazine’s 2011 Pharma Summit, Eli Lilly chairman, president and CEO John Lechleiter called for a new approach to research in such illnesses as Alzheimer’s disease, diabetes and cancer. This included changing the way companies conduct research and public policies that promote an environment in which innovation can flourish.

February 7, 2011

GlaxoSmithKline has received a license extension in Europe for its popular weight-loss pill Alli.

LONDON — GlaxoSmithKline has received a license extension in Europe for its popular weight-loss pill Alli.

The drug maker said it plans to sell new chewable tablets this spring, available at pharmacies throughout the United Kingdom.

Alli has been available in the United Kingdom since early 2009.

February 1, 2011

Thanks to technological innovations within mascara, the category has driven sales of eye makeup, and looking forward, mascara formulas that are infused with eyelash-enhancing treatments and packaging that offers greater customization not only will volumize lashes but also sales at retail.


Thanks to technological innovations within mascara, the category has driven sales of eye makeup, and looking forward, mascara formulas that are infused with eyelash-enhancing treatments and packaging that offers greater customization not only will volumize lashes but also sales at retail.


February 1, 2011

Yardley of London, the luxury bath products division of Lornamead, has announced the launch of two new scents for 2011. Pomegranate Rose and Cocoa Butter will join Yardley's line of moisturizing bath bars, which feature natural botanicals and essential oils.

STAMFORD, Conn. — Yardley of London, the luxury bath products division of Lornamead, has announced the launch of two new scents for 2011. Pomegranate rose and cocoa butter will join Yardley's line of moisturizing bath bars, which feature natural botanicals and essential oils.

January 27, 2011

The Food and Drug Administration declined to approve a regulatory approval application from British drug maker GlaxoSmithKline concerning a cancer drug, GSK said Wednesday.

LONDON — The Food and Drug Administration declined to approve a regulatory approval application from British drug maker GlaxoSmithKline concerning a cancer drug, GSK said Wednesday.

GSK said the FDA issued a complete response letter for its application seeking approval for Avodart (dutasteride) to reduce the risk of prostate cancer in men at increased risk of developing the disease. The drug already is approved to treat enlarged prostate.

January 19, 2011

The Advertising Standards Authority, an agency that regulates ads in Britain, said that Coca-Cola needs to stop running certain claims for its Vitaminwater brand.

LONDON — The Advertising Standards Authority, an agency that regulates ads in Britain, said that Coca-Cola needs to stop running certain claims for its Vitaminwater brand.

According to published reports, the agency said that Coca-Cola described the flavored water drinks as "delicious and nutritious" in ads that ran last year. The Advertising Standards Authority said that Vitaminwater's drinks contain 4 tsp to 5 tsp of sugar, and did not qualify to tout the "nutritious" claim.

January 18, 2011

Colin Mackenzie has been appointed the new president of GlaxoSmithKline Consumer Healthcare North America. Mackenzie succeeds Roger Scarlett-Smith, who is relocating to London to become president of GSK Consumer Healthcare Europe.

PITTSBURGH — Colin Mackenzie has been appointed the new president of GlaxoSmithKline Consumer Healthcare North America. Mackenzie succeeds Roger Scarlett-Smith, who is relocating to London to become president of GSK Consumer Healthcare Europe.

Mackenzie has been directing the U.S. oral care business since 2007. Under the leadership of MacKenzie, the business accelerated its net sales growth rate, acquired the leading dry mouth product, Biotene, in 2008, and claimed the No. 1 toothpaste SKU in the United States (Sensodyne Extra Whitening).

January 17, 2011

A new drug application for Anglo-Swedish drug maker AstraZeneca's vandetanib has been extended.

LONDON — A new drug application for Anglo-Swedish drug maker AstraZeneca's vandetanib has been extended.

The drug maker recently announced that the Food and Drug Administration asked AstraZeneca to submit a Risk Evaluation and Mitigation Strategy, which accordingly extended the Prescription Drug User Fee Act from Jan. 7 to April 7.

AstraZeneca will continue to work closely with the FDA to support the review of vandetanib, a drug for treating patients with advanced medullary thyroid cancer.

January 17, 2011

Drug maker GlaxoSmithKline will take a legal charge of $3.4 billion related to its promotion of a controversial diabetes drug.

LONDON — Drug maker GlaxoSmithKline will take a legal charge of $3.4 billion related to its promotion of a controversial diabetes drug.

The British company said the charge related to an investigation by the U.S. Attorney’s Office for the District of Colorado regarding sales and promotion of the drug Avandia (rosiglitazone) in spite of reports of the risk of heart attacks in patients taking it.

January 14, 2011

The battle for the prescription status of methamphetamine precursor/popular cough-cold ingredient pseudoephedrine now is heating up in Kentucky, just a few days following a Nevada news report that suggested the state will be considering PSE prescription-only requirements just as soon as a bill is introduced by Nevada Sen. Sheila Leslie, D-Reno.

FRANKFORT, Ky. — The battle for the prescription status of methamphetamine precursor/popular cough-cold ingredient pseudoephedrine now is heating up in Kentucky, just a few days following a Nevada news report that suggested the state will be considering PSE prescription-only requirements just as soon as a bill is introduced by Nevada Sen. Sheila Leslie, D-Reno.

January 10, 2011

Image-conscious women don't "dress their age" until they reach 70 years old, according to new research carried out by the retailer Debenhams, a department store group that a strong presence in such categories as women's clothing, shoes, children's wear and beauty.

LONDON — Image-conscious women don't "dress their age" until they reach 70 years old, according to new research carried out by the retailer Debenhams, a department store group that has a strong presence in such categories as women's clothing, shoes, children's wear and beauty.

December 22, 2010

British singer Marina Diamondis of Marina and the Diamonds has been selected as the new face of Max Factor, according to published reports.

LONDON — British singer Marina Diamondis of Marina and the Diamonds has been selected as the new face of Max Factor, according to published reports.

Diamondis will represent the beauty brand's Max Colour Effect Range in the new Big Night Out campaign, according to reports.

December 21, 2010

An Anglo-Swedish drug maker said it is discontinuing further development of a drug that is designed to prevent a respiratory virus that infects the lungs and breathing passages.

LONDON — An Anglo-Swedish drug maker said it is discontinuing further development of a drug that is designed to prevent a respiratory virus that infects the lungs and breathing passages.

AstraZeneca has requested the withdrawal of its pending biological license application for motavizumab from the Food and Drug Administration. Motavizumab is an investigational monoclonal antibody that could prevent serious respiratory syncytial virus disease.

AstraZeneca said it will incur a financial impairment charge of $445 million in fourth quarter 2010.

December 20, 2010

Unilever has confirmed that Alberto-Culver shareholders have approved the proposed $3.7 billion Unilever acquisition, which was announced in September.

LONDON and ROTTERDAM, Netherlands — Unilever has confirmed that Alberto-Culver shareholders have approved the proposed $3.7 billion Unilever acquisition, which was announced in September.

Separately, Unilever confirmed that it has received a second request for information from the United States Department of Justice in the regulatory review process. Unilever noted that it will continue to work with the DOJ in connection with its review.

December 16, 2010

GlaxoSmithKline will pay Impax Pharmaceuticals $11.5 million upfront to exclusively sell Impax's investigational Parkinson’s disease treatment.

LONDON and HAYWARD, Calif. — GlaxoSmithKline will pay Impax Pharmaceuticals $11.5 million upfront to exclusively sell Impax's investigational Parkinson’s disease treatment.

In addition to the $11.5 million upfront payment, Impax Pharmaceuticals, the branded drug division of Impax Labs, is eligible to receive potential payments of up to $175 million upon the successful achievement of development and commercialization milestones.

December 14, 2010

GlaxoSmithKline on Monday announced its acquisition from Darwin Private Equity of Maxinutrition, a U.K. company that manufactures protein-enhanced functional nutrition products.

LONDON — GlaxoSmithKline on Monday announced its acquisition from Darwin Private Equity of Maxinutrition, a U.K. company that manufactures protein-enhanced functional nutrition products.

“This deal will give GSK a strong presence in the fast-developing protein-based sports nutrition market, appealing across a broad spectrum of consumers, from elite athletes to sports participants and those seeking additional nutritional supplementation,” stated John Clarke, GSK Consumer Healthcare president.

December 7, 2010

Daily aspirin use may curb cancer-related deaths, according to a new study published in The Lancet.

LONDON — Daily aspirin use may curb cancer-related deaths, according to a new study published in The Lancet.

The study, led by Peter Rothwell of the University of Oxford and colleagues, analyzed data from eight eligible trials — which typically lasted about four years — and included more than 25,000 subjects. Among them, 674 died from cancer.

November 7, 2010

The Food and Drug Administration approved the first and only once-a-day metformin extended-release plus dipeptidyl...